News
March 5, 2012 — SynCardia Systems Inc., manufacturer of the world’s first and only U.S. Food and Drug Administration (FDA), Health Canada and Conformité Européenne (CE) approved Total Artificial Heart, announced that 18-year-old Jordan Merecka was successfully bridged to a heart transplant at Texas Children’s Hospital in Houston, Texas, after 160 days of support with the SynCardia temporary Total Artificial Heart.
March 05, 2012
Technology
March 5, 2012 — Emerge Clinical Solutions announced its strategic relationship with MedAxiom, a comprehensive subscription-based service provider and information resource exclusively for cardiology practices.
March 05, 2012
News
March 5, 2012 — Baxter International Inc. announced that it initiated a phase III pivotal clinical trial to evaluate the efficacy and safety of adult autologous (individual’s own) CD34+ stem cells to increase exercise capacity in patients with chronic myocardial ischemia (CMI).
March 05, 2012Sponsored Content
Feature | Information Technology
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
March 21, 2024News
March 1, 2012 — Cell>Point announced it entered into a licensing agreement for South Korea, Taiwan, Malaysia, Vietnam and the Philippines with Hyun Imc Co. Ltd., headquartered in Seoul, South Korea, for the kit manufacture, marketing and distribution of Cell>Point’s cancer and cardiology nuclear imaging product.
March 01, 2012Technology
March 1, 2012 — Philips announced the launch of HeartStart XL+, a crash cart defibrillator/monitor for use in hospitals and other health care facilities that, in AED mode, can defibrillate any patient with no special pads required, which can save valuable time when responding to a cardiac emergency.
March 01, 2012
Technology
March 1, 2012 – Steris Corp. announced they will collaborate with device manufacturer St. Jude Medical Inc. on the planning and implementation of advanced cardiac laboratories for healthcare providers in the United States. The labs feature technologies across the cardiovascular service line for hospitals and clinics interested in developing laboratories that meet their changing clinical needs.
March 01, 2012Sponsored Content
Feature | Cardiac Imaging
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
March 05, 2024News
February 29, 2012 — Vessix Vascular Inc. announced initial patient treatments in the international multi-center Reduce-HTN renal denervation clinical study for uncontrolled hypertension.
February 29, 2012
News
February 29, 2012 — Lantheus Medical Imaging Inc. announced a strategic distribution arrangement for its Definity cardiac ultrasound contrast agent in the People’s Republic of China, including Hong Kong S.A.R. and Macau S.A.R.
February 29, 2012News
February 28, 2012 — Janssen Research and Development LLC announced that the U.S. Food and Drug Administration (FDA) has assigned a priority review designation to the supplemental new drug application (sNDA) filed Dec. 29, 2011 for Xarelto (rivaroxaban).
February 28, 2012Sponsored Content
Blog
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
December 11, 2023
Feature
Based on what readers clicked on throughout 2011 on DIcardiology.com, following is a list of the top 25 most popular stories.
February 28, 2012
Technology
February 28, 2012 — AccessClosure Inc. announced the U.S. Food and Drug Administration (FDA) approval and U.S. launch of the MynxGrip Vascular Closure Device (VCD). Built on the Mynx platform, the MynxGrip VCD offers an active, extravascular and patient-friendly vascular closure solution.
February 28, 2012News
February 28, 2012 — nContact Inc. announced a new preclinical study examining a unique minimally invasive percutaneous approach to accessing the heart that may enable electrophysiologists (EPs) to perform epicardial ablation for ventricular tachycardia (VT). The study was published in the February 2012 issue of The Journal of Innovations in Cardiac Rhythm Management.
February 28, 2012Sponsored Content
Case Study | Hemodynamic Monitoring Systems
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
November 14, 2023
News
University Hospitals Case Medical Center and Case Western Reserve University School of Medicine (CWRU) researchers have uncovered a genetic factor that controls arrhythmias, the primary cause of sudden cardiac death (SCD) in the United States. The study will be published in the upcoming March edition of Nature entitled, “Circadian rhythms govern cardiac repolarization and arrhythmogenesis.”
February 28, 2012News
February 28, 2012 — Cambridge Consultants will demonstrate new Bluetooth low energy (BLE) iPhone 4S applications using CSR’s BLE devices at this year’s Mobile World Congress in Barcelona.
February 28, 2012
Feature
Jarvik Heart Inc. announced conditional U.S. Food and Drug Administration (FDA) approval of its pivotal trial for evaluation of the Jarvik 2000 heart for destination therapy (DT). Use of the device for DT means that it will provide long-term, permanent support to end-stage congestive heart failure patients who are not candidates for heart transplant.
February 28, 2012© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now